Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-033301
Filing Date
2013-06-06
Accepted
2013-06-06 17:13:02
Documents
1
Period of Report
2013-06-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd382648.html 4  
1 FORM 4 rrd382648.xml 4 4395
  Complete submission text file 0001181431-13-033301.txt   5771
Mailing Address 24 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803
Business Address 24 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803 781-652-4500
CORONADO BIOSCIENCES INC (Issuer) CIK: 0001429260 (see all company filings)

EIN.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CORONADO BIOSCIENCES, INC. 24 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803
Business Address
Avgerinos George (Reporting) CIK: 0001578699 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35366 | Film No.: 13898018